Cargando…
Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?
While PDE5 inhibitors have revolutionized treatment of ED, approximately 30% of patients are non-responsive. A significant cause of this is vascular and smooth muscle dysfunction, as well as nerve atrophy. Autologous administration of bone marrow mononuclear cells (BMMC) has been performed in over 2...
Autores principales: | Ichim, Thomas E, Warbington, Timothy, Cristea, Octav, Chin, Joseph L, Patel, Amit N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718667/ https://www.ncbi.nlm.nih.gov/pubmed/23758954 http://dx.doi.org/10.1186/1479-5876-11-139 |
Ejemplares similares
-
AB160. Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats
por: Qiu, Xuefeng, et al.
Publicado: (2015) -
Tracking Intracavernously Injected Adipose-Derived Stem Cells to Bone Marrow
por: Lin, Guiting, et al.
Publicado: (2011) -
Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
por: Al-Adl, Ahmed M., et al.
Publicado: (2011) -
Recurrent transient global amnesia after intracavernous Caverject injection in erectile dysfunction after robotic prostatectomy
por: Maffei, D., et al.
Publicado: (2020) -
Intracavernous Injection of Autologous Platelet-Rich Plasma Ameliorates Hyperlipidemia-Associated Erectile Dysfunction in a Rat Model
por: Huang, Yun-Ching, et al.
Publicado: (2021)